Keyphrases
Acute Ischemic Stroke
86%
National Institutes of Health Stroke Scale (NIHSS)
53%
Endovascular Treatment
50%
Intracerebral Hemorrhage
42%
Hmong
35%
United States
35%
Acute Stroke
28%
Stent Placement
27%
Minnesota
26%
Hematoma Expansion
25%
Systolic Blood Pressure
24%
Recanalization
24%
Clinical Trials
24%
Intravenous Thrombolysis
23%
Clinical Outcomes
20%
Quality Improvement Project
19%
Endovascular Procedures
19%
Intravenous Tissue Plasminogen Activator
19%
Stroke Patients
19%
Perihematomal Edema
18%
Major Stroke
17%
Vascular Neurosurgery
17%
Cross-cultural Adaptation
17%
Point-of-care Testing
17%
In-hospital Stroke
17%
Symptomatic Intracranial Stenosis
17%
Futile Recanalization
17%
Spontaneous Intracerebral Hemorrhage
17%
Systolic Blood Pressure Reduction
17%
Antihypertensive Treatment
17%
Acute Cerebral Hemorrhage
17%
Confidence Interval
16%
Acute Care
16%
Computed Tomography
15%
Ischemic Stroke
15%
Modified Rankin Scale
13%
High Risk
13%
Intra-arterial Thrombolysis
13%
Favorable Outcome
13%
Ischemic Stroke Patients
13%
POC Diagnostics
13%
Antiplatelet Agents
13%
Platelet Inhibition
13%
Odds Ratio
13%
Endovascular Intervention
12%
Readmission
12%
Acute Ischemic Stroke Patients
12%
White Patients
12%
Anticoagulation
11%
Thrombolytic Therapy
11%
Medicine and Dentistry
Apoplexy
100%
Brain Ischemia
77%
Cerebral Hemorrhage
57%
Blood Clot Lysis
30%
Clinical Trial
29%
Endovascular Surgery
26%
Stent Placement
25%
Alteplase
25%
Systolic Blood Pressure
20%
National Institutes of Health Stroke Scale
20%
Rehabilitation Engineering
19%
Recanalization
18%
Hematoma
18%
Emergency Care
17%
Angioplasty
17%
Intracranial Stenosis
17%
Point-of-Care Testing
17%
Quality Improvement
14%
Outpatient
14%
Anticoagulation
11%
Racial Disparity
11%
Antiplatelet Drug
11%
Platelet
11%
Nicardipine
10%
Thrombolytic Drug
9%
Emergency Department
9%
Symptom
9%
Diagnosis
8%
Carotid Artery Stenting
8%
Blood Pressure Reduction
8%
Kidney Injury
8%
Reteplase
8%
Central Retinal Artery Occlusion
8%
Transient Global Amnesia
8%
Retina Artery Occlusion
8%
Warfarin
8%
Variant Creutzfeldt-Jakob Disease
8%
Case-Control Study
8%
Neurological Complication
8%
Extracorporeal Membrane Oxygenation
8%
Neoplasm
8%
Eptifibatide
8%
COVID-19
8%
Drug-Eluting Stent
8%
Thrombus
8%
Cardioembolic Stroke
8%
Patient Care
8%
Primary Health Care
8%
Odds Ratio
8%
Stenosis
7%
